Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...